-
1
-
-
0031786344
-
Diabetes in America: epidemiology and scope of the problem
-
Harris MI (1998) Diabetes in America: epidemiology and scope of the problem. Diabetes Care 21(Suppl 3):C11–C14
-
(1998)
Diabetes Care
, vol.21
, pp. C11-C14
-
-
Harris, M.I.1
-
2
-
-
0034628425
-
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy
-
o A (2000) The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive insulin therapy. N Engl J Med 342:381–389
-
(2000)
N Engl J Med
, vol.342
, pp. 381-389
-
-
-
5
-
-
0031793875
-
The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes
-
Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1998) The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105:1801–1815
-
(1998)
Ophthalmology
, vol.105
, pp. 1801-1815
-
-
Klein, R.1
Klein, B.E.K.2
Moss, S.E.3
Cruickshanks, K.J.4
-
6
-
-
0022347471
-
Photocoagulation for diabetic macular edema
-
(1985) Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 103:1796–1806
-
Arch Ophthalmol
, vol.103
, pp. 1796-1806
-
-
-
7
-
-
84863221775
-
Stadieneinteilung und Therapie der diabetischen Retinopathie und Makulopathie
-
Nentwich NN, Lemmen KD, Ulbig MW (2010) Stadieneinteilung und Therapie der diabetischen Retinopathie und Makulopathie. Z prakt Augenheilkd 31:491–499
-
(2010)
Z prakt Augenheilkd
, vol.31
, pp. 491-499
-
-
Nentwich, N.N.1
Lemmen, K.D.2
Ulbig, M.W.3
-
8
-
-
54449089002
-
Diabetic macular edema: what is focal and what is diffuse?
-
Browning DJ, Altaweel MM, Bressler NM, Bressler SB, Scott IU, Diabetic Retinopathy Clinical Research Network (2008) Diabetic macular edema: what is focal and what is diffuse? Am J Ophthalmol 146(5):649–655
-
(2008)
Am J Ophthalmol
, vol.146
, Issue.5
, pp. 649-655
-
-
Browning, D.J.1
Altaweel, M.M.2
Bressler, N.M.3
Bressler, S.B.4
Scott, I.U.5
Network, D.R.C.R.6
-
9
-
-
77952271206
-
Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): report 1
-
Michaelides M, Fraser-Bell S, Hamilton R, Kaines A, Egan C, Bunce C, Peto T, Hykin P (2010) Macular perfusion determined by fundus fluorescein angiography at the 4-month time point in a prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (Bolt Study): report 1. Retina 30(5):781–786
-
(2010)
Retina
, vol.30
, Issue.5
, pp. 781-786
-
-
Michaelides, M.1
Fraser-Bell, S.2
Hamilton, R.3
Kaines, A.4
Egan, C.5
Bunce, C.6
Peto, T.7
Hykin, P.8
-
10
-
-
35548954255
-
Bevacizumab and retinal ischemia
-
Neubauer AS, Kook D, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW, Ceklic L (2007) Bevacizumab and retinal ischemia. Ophthalmology 114(11):2096
-
(2007)
Ophthalmology
, vol.114
, Issue.11
, pp. 2096
-
-
Neubauer, A.S.1
Kook, D.2
Haritoglou, C.3
Priglinger, S.G.4
Kampik, A.5
Ulbig, M.W.6
Ceklic, L.7
-
12
-
-
84868208071
-
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results
-
Diabetic Retinopathy Clinical Research Network, Elman MJ, Qin H, Aiello LP, Beck RW, Bressler NM, Ferris FL III, Glassman AR, Maturi RK, Melia M (2012) Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology 119(11):2312–2318
-
(2012)
Ophthalmology
, vol.119
, Issue.11
, pp. 2312-2318
-
-
Network, D.R.C.R.1
Elman, M.J.2
Qin, H.3
Aiello, L.P.4
Beck, R.W.5
Bressler, N.M.6
Ferris, F.L.I.I.I.7
Glassman, A.R.8
Maturi, R.K.9
Melia, M.10
-
13
-
-
84921555945
-
Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology
-
Elman MJ, Ayala A, Bressler NM, Browning D, Flaxel CJ, Glassman AR, Jampol LM, Stone TW, Diabetic Retinopathy Clinical Research Network (2014) Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results. Ophthalmology. doi:10.1016/j.ophtha.2014.08.047 (pii:S0161-6420(14)00821-5)
-
(2014)
doi:10.1016/j.ophtha.2014.08.047 (pii:S0161-6420(14)00821-5)
-
-
Elman, M.J.1
Ayala, A.2
Bressler, N.M.3
Browning, D.4
Flaxel, C.J.5
Glassman, A.R.6
Jampol, L.M.7
Stone, T.W.8
Network, D.R.C.R.9
-
14
-
-
84919904030
-
Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One 9(12):e113981
-
Liegl R, Langer J, Seidensticker F, Reznicek L, Haritoglou C, Ulbig MW, Neubauer AS, Kampik A, Kernt M (2014) Comparative evaluation of combined navigated laser photocoagulation and intravitreal ranibizumab in the treatment of diabetic macular edema. PLoS One 9(12):e113981. doi:10.1371/journal.pone.0113981 (eCollection 2014)
-
(2014)
doi:10.1371/journal.pone.0113981 (eCollection 2014)
-
-
Liegl, R.1
Langer, J.2
Seidensticker, F.3
Reznicek, L.4
Haritoglou, C.5
Ulbig, M.W.6
Neubauer, A.S.7
Kampik, A.8
Kernt, M.9
-
15
-
-
0027942607
-
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
-
Aiello LP, Avery RL, Arrigg PG, Keyt BA, Jampel HD, Shah ST, Pasquale LR, Thieme H, Iwamoto MA, Park JE et al (1994) Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331(22):1480–1487
-
(1994)
N Engl J Med
, vol.331
, Issue.22
, pp. 1480-1487
-
-
Aiello, L.P.1
Avery, R.L.2
Arrigg, P.G.3
Keyt, B.A.4
Jampel, H.D.5
Shah, S.T.6
Pasquale, L.R.7
Thieme, H.8
Iwamoto, M.A.9
Park, J.E.10
-
16
-
-
84892595109
-
Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab
-
Muether PS, Droege KM, Fauser S (2014) Vascular endothelial growth factor suppression times in patients with diabetic macular oedema treated with ranibizumab. Br J Ophthalmol 98(2):179–181
-
(2014)
Br J Ophthalmol
, vol.98
, Issue.2
, pp. 179-181
-
-
Muether, P.S.1
Droege, K.M.2
Fauser, S.3
-
17
-
-
33845745774
-
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema
-
Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A (2006) Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina 26(9):999–1005
-
(2006)
Retina
, vol.26
, Issue.9
, pp. 999-1005
-
-
Haritoglou, C.1
Kook, D.2
Neubauer, A.3
Wolf, A.4
Priglinger, S.5
Strauss, R.6
Gandorfer, A.7
Ulbig, M.8
Kampik, A.9
-
18
-
-
84873408164
-
Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months
-
Arevalo JF, Lasave AF, Wu L, Diaz-Llopis M, Gallego-Pinazo R, Alezzandrini AA, Berrocal MH, Pan-American Collaborative Retina Study Group (PACORES) (2013) Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-american Collaborative Retina Study Group at 24 months. Retina 33(2):403–413
-
(2013)
Retina
, vol.33
, Issue.2
, pp. 403-413
-
-
-
19
-
-
77952889192
-
A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2
-
Michaelides M, Kaines A, Hamilton RD, Fraser-Bell S, Rajendram R, Quhill F, Boos CJ, Xing W, Egan C, Peto T, Bunce C, Leslie RD, Hykin PG (2010) A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2. Ophthalmology 117(6):1078–1086
-
(2010)
Ophthalmology
, vol.117
, Issue.6
, pp. 1078-1086
-
-
Michaelides, M.1
Kaines, A.2
Hamilton, R.D.3
Fraser-Bell, S.4
Rajendram, R.5
Quhill, F.6
Boos, C.J.7
Xing, W.8
Egan, C.9
Peto, T.10
Bunce, C.11
Leslie, R.D.12
Hykin, P.G.13
-
20
-
-
84864444516
-
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema
-
Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, da Vinci Study Group (2012) One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119(8):1658–1665
-
(2012)
Ophthalmology
, vol.119
, Issue.8
, pp. 1658-1665
-
-
-
21
-
-
84908897529
-
Intravitreal aflibercept for diabetic macular edema
-
Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM (2014) Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121(11):2247–2254
-
(2014)
Ophthalmology
, vol.121
, Issue.11
, pp. 2247-2254
-
-
Korobelnik, J.F.1
Do, D.V.2
Schmidt-Erfurth, U.3
Boyer, D.S.4
Holz, F.G.5
Heier, J.S.6
Midena, E.7
Kaiser, P.K.8
Terasaki, H.9
Marcus, D.M.10
Nguyen, Q.D.11
Jaffe, G.J.12
Slakter, J.S.13
Simader, C.14
Soo, Y.15
Schmelter, T.16
Yancopoulos, G.D.17
Stahl, N.18
Vitti, R.19
Berliner, A.J.20
Zeitz, O.21
Metzig, C.22
Brown, D.M.23
more..
-
22
-
-
78049293726
-
Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study
-
Nguyen QD, Shah SM, Khwaja AA, Channa R, Hatef E, Do DV, Boyer D, Heier JS, Abraham P, Thach AB, Lit ES, Foster BS, Kruger E, Dugel P, Chang T, Das A, Ciulla TA, Pollack JS, Lim JI, Eliott D, Campochiaro PA, READ-2 Study Group (2010) Two-year outcomes of the ranibizumab for edema of the mAcula in diabetes (READ-2) study. Ophthalmology 117(11):2146–2151
-
(2010)
Ophthalmology
, vol.117
, Issue.11
, pp. 2146-2151
-
-
-
23
-
-
79251606719
-
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study
-
Massin P, Bandello F, Garweg JG, Hansen LL, Harding SP, Larsen M, Mitchell P, Sharp D, Wolf-Schnurrbusch UE, Gekkieva M, Weichselberger A, Wolf S (2010) Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care 33(11):2399–2405
-
(2010)
Diabetes Care
, vol.33
, Issue.11
, pp. 2399-2405
-
-
Massin, P.1
Bandello, F.2
Garweg, J.G.3
Hansen, L.L.4
Harding, S.P.5
Larsen, M.6
Mitchell, P.7
Sharp, D.8
Wolf-Schnurrbusch, U.E.9
Gekkieva, M.10
Weichselberger, A.11
Wolf, S.12
-
24
-
-
79953311138
-
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema
-
Mitchell P, Bandello F, Schmidt-Erfurth U, Lang GE, Massin P, Schlingemann RO, Sutter F, Simader C, Burian G, Gerstner O, Weichselberger A, RESTORE study group (2011) The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118(4):615–625
-
(2011)
Ophthalmology
, vol.118
, Issue.4
, pp. 615-625
-
-
-
25
-
-
84899902749
-
Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study
-
Schmidt-Erfurth U, Lang GE, Holz FG, Schlingemann RO, Lanzetta P, Massin P, Gerstner O, Bouazza AS, Shen H, Osborne A, Mitchell P, RESTORE Extension Study Group (2014) Three-year outcomes of individualized ranibizumab treatment in patients with diabetic macular edema: the RESTORE extension study. Ophthalmology 121(5):1045–1053
-
(2014)
Ophthalmology
, vol.121
, Issue.5
, pp. 1045-1053
-
-
-
26
-
-
84863401792
-
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE
-
Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group (2012) Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 119(4):789–801
-
(2012)
Ophthalmology
, vol.119
, Issue.4
, pp. 789-801
-
-
-
27
-
-
84885022258
-
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE
-
Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ, RIDE and RISE Research Group (2013) Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE. Ophthalmology 120(10):2013–2022
-
(2013)
Ophthalmology
, vol.120
, Issue.10
, pp. 2013-2022
-
-
-
28
-
-
79955557537
-
Intracameral injection of bevacizumab for the treatment of neovascular glaucoma
-
Wolf A, von Jagow B, Ulbig M, Haritoglou C (2011) Intracameral injection of bevacizumab for the treatment of neovascular glaucoma. Ophthalmologica 226(2):51–56
-
(2011)
Ophthalmologica
, vol.226
, Issue.2
, pp. 51-56
-
-
Wolf, A.1
von Jagow, B.2
Ulbig, M.3
Haritoglou, C.4
-
29
-
-
84880201329
-
Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy
-
Yang CS, Hung KC, Huang YM, Hsu WM (2013) Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy. J Ocul Pharmacol Ther 29(6):550–555
-
(2013)
J Ocul Pharmacol Ther
, vol.29
, Issue.6
, pp. 550-555
-
-
Yang, C.S.1
Hung, K.C.2
Huang, Y.M.3
Hsu, W.M.4
-
30
-
-
84911979513
-
Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema
-
Sun JK, Lin MM, Lammer J, Prager S, Sarangi R, Silva PS, Aiello LP (2014) Disorganization of the retinal inner layers as a predictor of visual acuity in eyes with center-involved diabetic macular edema. JAMA Ophthalmol 132(11):1309–1316
-
(2014)
JAMA Ophthalmol
, vol.132
, Issue.11
, pp. 1309-1316
-
-
Sun, J.K.1
Lin, M.M.2
Lammer, J.3
Prager, S.4
Sarangi, R.5
Silva, P.S.6
Aiello, L.P.7
-
31
-
-
84925423332
-
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema
-
Diabetic Retinopathy Clinical Research Network, Wells JA, Glassman AR, Ayala AR, Jampol LM, Aiello LP, Antoszyk AN, Arnold-Bush B, Baker CW, Bressler NM, Browning DJ, Elman MJ, Ferris FL, Friedman SM, Melia M, Pieramici DJ, Sun JK, Beck RW (2015) Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med 372(13):1193–1203
-
(2015)
N Engl J Med
, vol.372
, Issue.13
, pp. 1193-1203
-
-
Network, D.R.C.R.1
Wells, J.A.2
Glassman, A.R.3
Ayala, A.R.4
Jampol, L.M.5
Aiello, L.P.6
Antoszyk, A.N.7
Arnold-Bush, B.8
Baker, C.W.9
Bressler, N.M.10
Browning, D.J.11
Elman, M.J.12
Ferris, F.L.13
Friedman, S.M.14
Melia, M.15
Pieramici, D.J.16
Sun, J.K.17
Beck, R.W.18
-
32
-
-
10044242430
-
Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone
-
Brooks HL Jr, Caballero S Jr, Newell CK, Steinmetz RL, Watson D, Segal MS, Harrison JK, Scott EW, Grant MB (2004) Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122:1801–1807
-
(2004)
Arch Ophthalmol
, vol.122
, pp. 1801-1807
-
-
Brooks, H.L.1
Caballero, S.2
Newell, C.K.3
Steinmetz, R.L.4
Watson, D.5
Segal, M.S.6
Harrison, J.K.7
Scott, E.W.8
Grant, M.B.9
-
33
-
-
0036240895
-
Intravitreal triamcinolone for refractory diabetic macular edema
-
Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E, Baumal C (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109(5):920–927
-
(2002)
Ophthalmology
, vol.109
, Issue.5
, pp. 920-927
-
-
Martidis, A.1
Duker, J.S.2
Greenberg, P.B.3
Rogers, A.H.4
Puliafito, C.A.5
Reichel, E.6
Baumal, C.7
-
34
-
-
76549110743
-
Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema
-
Kreutzer TC, Al Saeidi R, Kook D, Wolf A, Ulbig MW, Neubauer AS, Haritoglou C (2010) Comparison of intravitreal bevacizumab versus triamcinolone for the treatment of diffuse diabetic macular edema. Ophthalmologica 224(4):258–264
-
(2010)
Ophthalmologica
, vol.224
, Issue.4
, pp. 258-264
-
-
Kreutzer, T.C.1
Al Saeidi, R.2
Kook, D.3
Wolf, A.4
Ulbig, M.W.5
Neubauer, A.S.6
Haritoglou, C.7
-
35
-
-
84908118639
-
Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema
-
Boyer DS, Yoon YH, Belfort R Jr, Bandello F, Maturi RK, Augustin AJ, Li XY, Cui H, Hashad Y, Whitcup SM, Ozurdex MEAD Study Group (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121(10):1904–1914
-
(2014)
Ophthalmology
, vol.121
, Issue.10
, pp. 1904-1914
-
-
-
36
-
-
84867099927
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema
-
Campochiaro PA, Brown DM, Pearson A, Chen S, Boyer D, Ruiz-Moreno J, Garretson B, Gupta A, Hariprasad SM, Bailey C, Reichel E, Soubrane G, Kapik B, Billman K, Kane FE, Green K, FAME Study Group (2012) Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology 119(10):2125–2132
-
(2012)
Ophthalmology
, vol.119
, Issue.10
, pp. 2125-2132
-
-
-
37
-
-
0023814808
-
The role of the vitreous in diabetic macular edema
-
Nasrallah FP, Jalkh AE, VanCoppenrolle F, Kado M, Trempe CL, McMeel JW, Schepens CL (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95:1335–1339
-
(1988)
Ophthalmology
, vol.95
, pp. 1335-1339
-
-
Nasrallah, F.P.1
Jalkh, A.E.2
VanCoppenrolle, F.3
Kado, M.4
Trempe, C.L.5
McMeel, J.W.6
Schepens, C.L.7
-
38
-
-
0030997154
-
Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus
-
Hikichi T, Fujio N, Akiba Y, Takahashi M, Yoshida A (1997) Association between the short-term natural history of diabetic macular edema and the vitreomacular relationship in type II diabetes mellitus. Ophthalmology 104:473–478
-
(1997)
Ophthalmology
, vol.104
, pp. 473-478
-
-
Hikichi, T.1
Fujio, N.2
Akiba, Y.3
Takahashi, M.4
Yoshida, A.5
-
39
-
-
0029949176
-
Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane
-
Harbour JW, Smiddy WE, Flynn HW, Rubsamen PE (1996) Vitrectomy for diabetic macular edema associated with a thickened and taut posterior hyaloid membrane. Am J Ophthalmol 121:405–413
-
(1996)
Am J Ophthalmol
, vol.121
, pp. 405-413
-
-
Harbour, J.W.1
Smiddy, W.E.2
Flynn, H.W.3
Rubsamen, P.E.4
-
42
-
-
0035158482
-
The role of vitrectomy in the treatment of diabetic macular edema
-
Lewis H (2001) The role of vitrectomy in the treatment of diabetic macular edema. Am J Ophthalmol 131:123–125
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 123-125
-
-
Lewis, H.1
-
44
-
-
0034122047
-
Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane
-
Gandorfer A, Messmer EM, Ulbig MW, Kampik A (2000) Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 20(2):126–133
-
(2000)
Retina
, vol.20
, Issue.2
, pp. 126-133
-
-
Gandorfer, A.1
Messmer, E.M.2
Ulbig, M.W.3
Kampik, A.4
|